These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 25622239

  • 1. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V, Tomic J, Klaic DZ, Kasum M, Kuna K.
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.
    Ganesh A, Chakravorty N, Mukherjee R, Goswami S, Chaudhury K, Chakravarty B.
    Fertil Steril; 2011 May; 95(6):1961-5. PubMed ID: 21333984
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral dydrogesterone vs. micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients.
    Ozer G, Yuksel B, Yucel Cicek OS, Kahraman S.
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102030. PubMed ID: 33271319
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles.
    Saharkhiz N, Zamaniyan M, Salehpour S, Zadehmodarres S, Hoseini S, Cheraghi L, Seif S, Baheiraei N.
    Gynecol Endocrinol; 2016 May; 32(3):213-7. PubMed ID: 26486011
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study.
    Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S.
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):416-20. PubMed ID: 16213136
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
    Kleinstein J, Luteal Phase Study Group.
    Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
    [Abstract] [Full Text] [Related]

  • 10. Crinone Gel for Luteal Phase Support in Frozen-Thawed Embryo Transfer Cycles: A Prospective Randomized Clinical Trial in the Chinese Population.
    Wang Y, He Y, Zhao X, Ji X, Hong Y, Wang Y, Zhu Q, Xu B, Sun Y.
    PLoS One; 2015 Jun; 10(7):e0133027. PubMed ID: 26222435
    [Abstract] [Full Text] [Related]

  • 11. Vaginal use of micronized progesterone for luteal support.A randomized study comparing Utrogestan® and Crinone® 8.
    Michnova L, Dostal J, Kudela M, Hamal P, Langova K.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):86-91. PubMed ID: 28323291
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support in blastocyst stage embryo transfers.
    Wang LJ, Huang FJ, Kung FT, Lin PY, Chang SY, Lan KC.
    Taiwan J Obstet Gynecol; 2009 Dec; 48(4):375-9. PubMed ID: 20045758
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.
    Simunic V, Tomic V, Tomic J, Nizic D.
    Fertil Steril; 2007 Jan; 87(1):83-7. PubMed ID: 17081536
    [Abstract] [Full Text] [Related]

  • 16. Vaginal (Crinone 8%) gel vs. intramuscular progesterone in oil for luteal phase support in in vitro fertilization: a large prospective trial.
    Silverberg KM, Vaughn TC, Hansard LJ, Burger NZ, Minter T.
    Fertil Steril; 2012 Feb; 97(2):344-8. PubMed ID: 22188983
    [Abstract] [Full Text] [Related]

  • 17. Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis.
    Griesinger G, Blockeel C, Kahler E, Pexman-Fieth C, Olofsson JI, Driessen S, Tournaye H.
    PLoS One; 2020 Feb; 15(11):e0241044. PubMed ID: 33147288
    [Abstract] [Full Text] [Related]

  • 18. Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study.
    Yanushpolsky E, Hurwitz S, Greenberg L, Racowsky C, Hornstein M.
    Fertil Steril; 2010 Dec; 94(7):2596-9. PubMed ID: 20347079
    [Abstract] [Full Text] [Related]

  • 19. Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial.
    Saunders H, Khan C, D'Hooghe T, Magnúsdóttir TB, Klingmann I, Hrafnsdóttir S, vaginal progesterone luteal phase support post IVF study group.
    Hum Reprod; 2020 Feb 29; 35(2):355-363. PubMed ID: 32074281
    [Abstract] [Full Text] [Related]

  • 20. Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study.
    Lockwood G, Griesinger G, Cometti B, 13 European Centers.
    Fertil Steril; 2014 Jan 29; 101(1):112-119.e3. PubMed ID: 24140033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.